Cowen And Company, LLC Biogen Inc. Put Options Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 09, 2023	BUY	$252.44 - $306.72 $1.09 Million - $1.32 Million	4,300 New	4,300 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.68 Million - $2.16 Million	7,500 New	7,500 $42,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $905,568 - $1.18 Million	-3,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $828,800 - $1.33 Million	3,200 New	3,200 $39,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.